Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal J Meropol

Showing results (121-130 of 226) with videos related to

Pageof 23
Sort By:
Cancer Chemotherapy and Pharmacology|August 8, 2012
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumorsJoanna M Brell, Smitha S Krishnamurthi, Linda Rath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfactionWenchi Liang, Caroline B Burnett, Julia H Rowland, et al.
European Urology Oncology|April 25, 2019
Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and UrologistsSimon P Kim, Nilay D Shah, Neal J Meropol, et al.
Cancer Informatics|December 16, 2014
Trial prospector: matching patients with cancer research studies using an automated and scalable approachSatya S Sahoo, Shiqiang Tao, Andrew Parchman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancerSteven J Cohen, Cynthia G Leichman, Gwen Yeslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of careJeanne S Mandelblatt, Stephen B Edge, Neal J Meropol, et al.
Journal of Gastrointestinal Cancer|February 2, 2012
A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research studyEfrat Dotan, Neal J Meropol, Barbara Burtness, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancerNeal J Meropol, Philip J Gold, Robert B Diasio, et al.
Health Education Research|August 6, 2009
Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancerSharon L Manne, Elliot J Coups, Gary Winkel, et al.
Annals of Surgical Oncology|January 19, 2006
Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II reportLeonard R Henry, Melvyn Goldberg, Walter Scott, et al.
Pageof 23

Showing results (121-130 of 226) with videos related to

Sort By:
Pageof 23
Cancer Chemotherapy and Pharmacology|August 8, 2012
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumorsJoanna M Brell, Smitha S Krishnamurthi, Linda Rath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfactionWenchi Liang, Caroline B Burnett, Julia H Rowland, et al.
European Urology Oncology|April 25, 2019
Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and UrologistsSimon P Kim, Nilay D Shah, Neal J Meropol, et al.
Cancer Informatics|December 16, 2014
Trial prospector: matching patients with cancer research studies using an automated and scalable approachSatya S Sahoo, Shiqiang Tao, Andrew Parchman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancerSteven J Cohen, Cynthia G Leichman, Gwen Yeslow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of careJeanne S Mandelblatt, Stephen B Edge, Neal J Meropol, et al.
Journal of Gastrointestinal Cancer|February 2, 2012
A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research studyEfrat Dotan, Neal J Meropol, Barbara Burtness, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancerNeal J Meropol, Philip J Gold, Robert B Diasio, et al.
Health Education Research|August 6, 2009
Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancerSharon L Manne, Elliot J Coups, Gary Winkel, et al.
Annals of Surgical Oncology|January 19, 2006
Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II reportLeonard R Henry, Melvyn Goldberg, Walter Scott, et al.
Pageof 23